Literature DB >> 28732712

Structure-Performance Relationships of Temperature-Responsive PLGA-PEG-PLGA Gels for Sustained Release of Bone Morphogenetic Protein-2.

Ana Santoveña1, Cecilia Monzón2, Carmen Alvarez-Lorenzo3, Carlos Del Rosario2, Araceli Delgado2, Carmen Evora2, Angel Concheiro3, Matias Llabrés4, José B Fariña4.   

Abstract

PLGA (poly(lactic-co-glycolic) acid)-PEG (polyethylene glycol)-PLGA synthesis conditions have an impact on the physicochemical features of the copolymer and its usefulness as biomaterial. This study reports on an analysis of the composition and structural properties of PLGA-PEG-PLGA copolymers applying a variety of analytical techniques. Viscoelastic properties and particularly the temperature-responsive behavior of PLGA-PEG-PLGA showed a marked dependence on copolymer structural features. Physicochemical and biological properties, such as bioadhesion, biocompatibility and cell viability, of the raw copolymers and their gels were also evaluated. The most promising copolymer was chosen to formulate the osteoinductive protein bone morphogenetic protein-2 (125I-BMP-2), and the ability of its gels to sustain the release both in vitro and in vivo was monitored in situ using a gamma counter. In vitro diffusion studies were carried out using a bioinspired set-up that included a biorelevant receptor medium. In vivo release tests after implantation in a critical-size calvarial defect model showed an important burst, but then the release fitted well to the square-root kinetics. Importantly, the release rate constants recorded in vitro and in vivo matched each other suggesting close in vitro-in vivo correlation. Overall, the information gathered opens new perspectives in the biomedical application of these temperature-sensitive materials.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMP-2; PLGA-PEG-PLGA copolymer; gel depots; in vivo release rate; sol-gel transition temperature

Mesh:

Substances:

Year:  2017        PMID: 28732712     DOI: 10.1016/j.xphs.2017.07.007

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Antibiofilm Coatings Based on PLGA and Nanostructured Cefepime-Functionalized Magnetite.

Authors:  Denisa Ficai; Valentina Grumezescu; Oana Mariana Fufă; Roxana Cristina Popescu; Alina Maria Holban; Anton Ficai; Alexandru Mihai Grumezescu; Laurentiu Mogoanta; George Dan Mogosanu; Ecaterina Andronescu
Journal:  Nanomaterials (Basel)       Date:  2018-08-21       Impact factor: 5.076

Review 2.  Supramolecular Hydrogels for Protein Delivery in Tissue Engineering.

Authors:  Yaqi Lyu; Helena S Azevedo
Journal:  Molecules       Date:  2021-02-07       Impact factor: 4.411

3.  Hydrogel-hydroxyapatite-monomeric collagen type-I scaffold with low-frequency electromagnetic field treatment enhances osteochondral repair in rabbits.

Authors:  Jiyuan Yan; Chaoxu Liu; Chang Tu; Ruizhuo Zhang; Xiangyu Tang; Hao Li; Huaixi Wang; Yongzhuang Ma; Yingchi Zhang; Hua Wu; Gaohong Sheng
Journal:  Stem Cell Res Ther       Date:  2021-11-13       Impact factor: 6.832

4.  Design and Development of Nanostructured Co Delivery of Artemisinin and Chrysin for Targeting hTERT Gene Expression in Breast Cancer Cell Line: Possible Clinical Application in Cancer Treatment.

Authors:  Leila Khoshravan; Mehdi Dadashpour; Mehrdad Hashemi; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2022-03-01

Review 5.  Stimuli-Responsive Delivery of Growth Factors for Tissue Engineering.

Authors:  Moyuan Qu; Xing Jiang; Xingwu Zhou; Canran Wang; Qingzhi Wu; Li Ren; Jixiang Zhu; Songsong Zhu; Peyton Tebon; Wujin Sun; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2020-03-03       Impact factor: 9.933

Review 6.  Self-Assemblable Polymer Smart-Blocks for Temperature-Induced Injectable Hydrogel in Biomedical Applications.

Authors:  Thai Thanh Hoang Thi; Le Hoang Sinh; Dai Phu Huynh; Dai Hai Nguyen; Cong Huynh
Journal:  Front Chem       Date:  2020-01-31       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.